Neuroprotection after a first episode of mania: a randomized controlled maintenance trial comparing the effects of lithium and quetiapine on grey and white matter volume
Open Access
- 24 January 2017
- journal article
- research article
- Published by Springer Science and Business Media LLC in Translational Psychiatry
- Vol. 7 (1), e1011
- https://doi.org/10.1038/tp.2016.281
Abstract
Lithium and quetiapine are effective treatments for bipolar disorder, but their potential neuroprotective effects in humans remain unclear. A single blinded equivalence randomized controlled maintenance trial was conducted in a prospective cohort of first-episode mania (FEM) patients (n=26) to longitudinally compare the putative protective effects of lithium and quetapine on grey and white matter volume. A healthy control sample was also collected (n=20). Using structural MRI scans, voxel-wise grey and white matter volumes at baseline and changes over time in response to treatment were investigated. Patients were assessed at three time points (baseline, 3 and 12-month follow-up), whereas healthy controls were assessed at two time points (baseline and 12-month follow-up). Patients were randomized to lithium (serum level 0.6 mmol l−1, n=20) or quetiapine (flexibly dosed up to 800 mg per day, n=19) monotherapy. At baseline, compared with healthy control subjects, patients with FEM showed reduced grey matter in the orbitofrontal cortex, anterior cingulate, inferior frontal gyrus and cerebellum. In addition, patients had reduced internal capsule white matter volume bilaterally (t1,66>3.20, P2,112=8.54, PPost hoc testing showed that, compared with baseline, lithium was more effective than quetiapine in slowing the progression of white matter volume reduction after 12 months (t1,24=3.76, P<0.01). Our data support the role of lithium but not quetiapine therapy in limiting white matter reduction early in the illness course after FEM.This publication has 59 references indexed in Scilit:
- Lithium enhances remyelination of peripheral nervesProceedings of the National Academy of Sciences of the United States of America, 2012
- One‐year psychosocial functioning in patients in the early vs. late stage of bipolar disorderActa Psychiatrica Scandinavica, 2012
- Longitudinal changes in brain structure following the first episode of psychosisPsychiatry Research: Neuroimaging, 2011
- The effects of lithium and anticonvulsants on brain structure in bipolar disorderActa Psychiatrica Scandinavica, 2010
- Lithium-Induced Gray Matter Volume Increase As a Neural Correlate of Treatment Response in Bipolar Disorder: A Longitudinal Brain Imaging StudyNeuropsychopharmacology, 2010
- Preliminary evidence for progressive prefrontal abnormalities in adolescents and young adults with bipolar disorderJournal of the International Neuropsychological Society, 2009
- Prefrontal gray matter increases in healthy individuals after lithium treatment: A voxel-based morphometry studyNeuroscience Letters, 2007
- A fast diffeomorphic image registration algorithmNeuroImage, 2007
- Neocortical Gray Matter Volume in First-Episode Schizophrenia and First-Episode Affective Psychosis: A Cross-Sectional and Longitudinal MRI StudyBiological Psychiatry, 2007
- A New Depression Scale Designed to be Sensitive to ChangeThe British Journal of Psychiatry, 1979